PETERSBURG, VA—Eleven months after Boehringer Ingelheim put its 219-acre campus on the market, it has found a buyer: UniTao Pharmaceuticals LLC, a subsidiary of Shanghai-based Tenry Pharmaceutical Co., Ltd., is acquiring the spread.

The company manufactures active pharmaceutical ingredients and it plans to invest $22.5 million in the facility to establish its operations at the site. This will follow Boehringer Ingelheim’s more than $150 million investment in the 85-acre site since it started developing it in 2008.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

Dig Deeper

 

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2022 ALM Global, LLC. All Rights Reserved.